ViTToria Biotherapeutics logo

ViTToria Biotherapeutics

Philadelphia, PA

Vittoria Biotherapeutics develops gene-edited cell therapies. they provide next-generation, paradigm-shifting T-cell therapeutics that address unmet medical needs. Senza5 Technology from viTToria improves the efficacy, safety, and utility of cell-based treatments in preclinical settings.

vittoriabio.com

Company Details

Founded

2021

Employees

Between 20 - 50 employees

Raised

$25,000,000

Headquarters Location

Philadelphia, PA

Public

No

Acquired

No

CEO

Nicholas SicilianoNicholas Siciliano

Founders

Bruce Peacock
Bruce Peacock
Marco Ruella
Marco Ruella
Nicholas Siciliano
Nicholas Siciliano

Company Collections

These are collections ViTToria Biotherapeutics is a part of. Click on the collection name to view similar companies.

ViTToria Biotherapeutics' Industries

ViTToria Biotherapeutics' Tech Stack

ViTToria Biotherapeutics Headquarters Location

3675 Market Street Suite 200, Philadelphia, PA 19104

Total Amount Raised: $25,000,000

ViTToria Biotherapeutics Funding Rounds

  • Series Unknown

    $15,000,000

    Series Unknown Investors

    Valley Forge Investment
    Bioadvance
    Tellus BioVentures
    NYBC Ventures
    The Leukemia & Lymphoma Society's Therapy Acceleration Program
    Agent Capital
    University of Pennsylvania (Penn)

  • Seed

    $10,000,000

    Seed Investors

    Agent Capital
    Tellus BioVentures
    SV Health Investors
    Penn Medicine Co-Investment Program
Funding info provided by Diffbot.

ViTToria Biotherapeutics Reviews

0 out of 5 stars

Based on 0 reviews

Review data

Share your thoughts

Worked here? Share your experience. Help others decide if this company is right for them. Write a review on ViTToria Biotherapeutics.

Recent reviews